Home
>
National Drug Code (NDC)
>
Ondansetron
Ondansetron - 45963-539-30 - (Ondansetron)
Drug Information of Ondansetron
| Product NDC: | 45963-539 |
| Proprietary Name: | Ondansetron |
| Non Proprietary Name: | Ondansetron |
| Active Ingredient(s): | 8 mg/1 & nbsp; Ondansetron |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ondansetron
| Product NDC: | 45963-539 |
| Labeler Name: | Actavis Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077851 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070727 |
Package Information of Ondansetron
| Package NDC: | 45963-539-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (45963-539-30) |
NDC Information of Ondansetron
| NDC Code | 45963-539-30 |
| Proprietary Name | Ondansetron |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (45963-539-30) |
| Product NDC | 45963-539 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ondansetron |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070727 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Inc. |
| Substance Name | ONDANSETRON HYDROCHLORIDE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
